| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.042 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |